Investing in biotech and pharmaceutical stocks is often more challenging than other forms of investments. While analyzing retail stock, such as Wal-Mart, for example, requires understanding of the firm's balance sheet and operations, most people are familiar with the basic business model of the large department store, and thus would feel more comfortable with the share purchase. The home country bias suggests that investors fail to diversify their holdings across international boarders because they are familiar and comfortable with the domestic selection of stocks.

IN PICTURES: World's Greatest Investors

Going Beyond Your Comfort Zone
Generally, typical investment strategies involve analysis of the securities that people are familiar with. Start-up firms often have difficulty attracting investors because only those who are familiar with their operations will invest the desired capital. Most people who wish to diversify their portfolios to incorporate a pharmaceutical component will purchase well-known and established firms such as Pfizer (NYSE:PFE), Merck (NYSE:MRK), Johnson & Johnson (NYSE:JNJ) or simply a pharmaceutical ETF such as Pharmaceutical HOLDRs (AMEX:PPH). While such investments are definitely suitable for almost any type of investor, there are some other intriguing large and small cap stocks that do not have the same type of mainstream recognition as the aforementioned companies.

A Home Run in Biotechnology
Human Genome Sciences (Nasdaq:HGSI) is a $5.2 billion pharmaceutical company that has returned over 1,000% in the last year. After its successful phase three testing, Human Genome Sciences is waiting FDA approval for BENLYSTA, the first approved drug in 50 years which treats Lupus. Barclay's Capital is optimistic about the drug since "the trials they did and the trial design was sufficient, and those trials were successful." With more major drugs in the pipeline, particularly ZALBIN, which would treat chronic hepatitis C, HGSI has the potential to create several blockbuster drugs.

Although Human Genome Sciences trades with a beta of 5.06, in addition to a price-to-sales and price-to-book significantly larger than the industry average, official FDA approval of its drug will justify the high multiples.

A Specialty Pharmaceutical Company
Somaxon Pharmaceuticals (Nasdaq:SOMX) also had an impressive year, and increased the value of its shares by 360% year to date. In the highlights of their latest quarterly report, Somaxon noted that the FDA approved the New Drug Application for Silenor used in treating insomnia. Since the pharmaceutical company is still in the development stages, it did not generate revenues in the first quarter of 2010. However, Somaxon has cash of and cash equivalents of 58.5 million with no debt on its balance sheet.

The Drive to Discover
Incyte Corporation (Nasdaq:INCY) creates drugs for hematologic and oncology indications, in addition to chronic inflammatory and autoimmune diseases. It currently has several drugs in the pipeline which target such major ailments as Myelofibrosis and Arthritis. According to MarketWatch, the average target price for Incyte is $17, almost $4 higher than its current trading range. With a beta of 2.38, INCY is a fairly volatile stock, and should be researched carefully. Over the past year, shares returned 310%.

The Bottom Line
In addition to the well known pharmaceutical companies, investors should consider adding some of the other players as well. Although some of these may be more risky, they have the potential to produce significant capital gains. (To learn more about the industry, check out Measuring the Medicine Makers.)

Use the Investopedia Stock Simulator to trade the stocks mentioned in this stock analysis, risk free!

Related Articles
  1. Mutual Funds & ETFs

    Top Three Transportation ETFs

    These three transportation funds attract the majority of sector volume.
  2. Stock Analysis

    5 Cheap Dividend Stocks for a Bear Market

    Here are five stocks that pay safe dividends and should be at least somewhat resilient to a bear market.
  3. Investing Basics

    Tops Tips for Trading ETFs

    A look at two different trading strategies for ETFs - one for investors and the other for active traders.
  4. Investing

    How to Win More by Losing Less in Today’s Markets

    The further you fall, the harder it is to climb back up. It’s a universal truth that is painfully apparent in the investing world.
  5. Fundamental Analysis

    Use Options Data To Predict Stock Market Direction

    Options market trading data can provide important insights about the direction of stocks and the overall market. Here’s how to track it.
  6. Stock Analysis

    2 Oil Stocks to Buy Right Now (PSX,TSO)

    Can these two oil stocks buck the trend?
  7. Investing News

    What Alcoa’s (AA) Breakup Means for Investors

    Alcoa plans to split into two companies. Is this a bullish catalyst for investors?
  8. Mutual Funds & ETFs

    Top 4 Investment Grade Corporate Bonds ETFs

    Discover detailed analysis and information about some of the top exchange-traded funds (ETFs) that offer exposure to the investment-grade corporate bond market.
  9. Stock Analysis

    Top 3 Stocks for the Coming Holiday Season

    If you want to buck the bear market trend by going long on consumer stocks, these three might be your best bets.
  10. Investing News

    Could a Rate Hike Send Stocks Higher?

    A rate hike would certainly alter the investment scene, but would it be for the better or worse?
  1. Can mutual funds invest in IPOs?

    Mutual funds can invest in initial public offerings (IPOS). However, most mutual funds have bylaws that prevent them from ... Read Full Answer >>
  2. How do dividends affect retained earnings?

    When a company issues a cash dividend to its shareholders, the retained earnings listed on the balance sheet are reduced ... Read Full Answer >>
  3. What is the difference between called-up share capital and paid-up share capital?

    The difference between called-up share capital and paid-up share capital is investors have already paid in full for paid-up ... Read Full Answer >>
  4. Why would a corporation issue convertible bonds?

    A convertible bond represents a hybrid security that has bond and equity features; this type of bond allows the conversion ... Read Full Answer >>
  5. Does index trading increase market vulnerability?

    The rise of index trading may increase the overall vulnerability of the stock market due to increased correlations between ... Read Full Answer >>
  6. What does a high turnover ratio signify for an investment fund?

    If an investment fund has a high turnover ratio, it indicates it replaces most or all of its holdings over a one-year period. ... Read Full Answer >>

You May Also Like

Trading Center
You are using adblocking software

Want access to all of Investopedia? Add us to your “whitelist”
so you'll never miss a feature!